期刊文献+

特发性非肝硬化性门静脉高压症的研究进展 被引量:3

Idiopathic non-cirrhotic portal hypertension
下载PDF
导出
摘要 特发性非肝硬化性门静脉高压是一种原因不明的门静脉高压症,无明显肝硬化特征;本病的发病机制尚不清楚,目前认为慢性感染、免疫、毒物接触、凝血机制障碍等均可能参与发病。临床主要表现为门静脉高压征象,如食管胃底静脉曲张或破裂出血、显著脾肿大,而肝功能基本正常,腹水及肝性脑病少见;病理改变主要表现为门静脉闭塞性病变,但无肝硬化改变。临床诊断主要是排他性诊断,有门静脉高压的临床证据,组织病理学检查除外肝硬化,排除引起肝硬化的慢性肝病以及引起非肝硬化性门静脉高压的其他临床疾病即可考虑本病。有关特发性非肝硬化性门静脉高压症研究较少,推荐按照肝硬化所致门静脉高压指南进行治疗。预后主要取决于门静脉高压的严重程度及其并发症的处理,一般优于肝硬化并食管胃底静脉曲张破裂出血。 he pathogenesis of idiopathic non -cirrhotic portal hypertension (INCPH) remains unknown and the disease is diagnosed by the absence of recognized clinical indicators of cirrhosis and of any other known etiologies of portal hypertension. To promote understanding of this disease, a comprehensive overview of potential etiologies, clinical manifestations, histopathological features, methods of diagnosis and potential differential diagnoses, and outcome of clinical management is presented in this review. In particular, we discuss the findings from INCPH studies and their implications in regards to each of the above - mentioned categories. For example, associations with various comor- bidities have suggested a possible immune system component to INCPH development and/or progression. In addition, the common clinical characteristics of patients upon presentation can not only help to recognize disease suspects but may also provide insights into the pathogenesis and prognosis. Finally, prognosis following the various intervention strategies appears to depend mainly on severity of the portal hypertension, as well as its various accmnpanying complications.
作者 陈杰
出处 《临床肝胆病杂志》 CAS 2013年第4期311-313,共3页 Journal of Clinical Hepatology
关键词 特发性非肝硬化性门静脉高压 食管和胃静脉曲张 肝静脉闭塞性疾病 idiopathic noncirrhotic portal hypertension esophageal and gastric varices hepatic veno - occlusive disease
  • 相关文献

参考文献21

  • 1Vispo E, Moreno A, Maida I, et al. Noncirrhotic portal hyper- tension in HIV -infected patients= unique clinical and patho- logical findings[J]. AIDS, 2010, 24(8} = 1171 -1176.
  • 2Vernier - Massouille G, Cosnes J, Lemann M, et al. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine [ J ]. Gut, 2007, 56 ( 10 ) ; 1404 - 1409.
  • 3Guha Mazumder DN. Chronic arsenic toxicity & human health [J]. Indian J Med Res, 2008, 128(4)..436-447.
  • 4Cazals -Hatem D, Hillaire S, Rudler M, et al. Obliterative portal venopathy= portal hypertension is not always present at diagnosis[J]. J Hepatol, 2011, 54(3} 455 -461.
  • 5Blendis LM, Banks DC, Ramboer C, et al. Spleen blood flow and splanchnic haemodynamics in blood dyscrasia and other splenomegalies[J]. Clin Sci, 1970, 38(1 }= 73 -84.
  • 6Yamaguchi E, Yamanoi A, One T, et al. Experimental investiga- tion of the role of endothelin -1 in idiopathic portal hypertension [J]. J Gastroenterol Hepatol, 2007, 22(7) = 1134-1140.
  • 7Dabritz J, Worch J, Materna U, et al. Life -threatening hy- persplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature[J]. BMC Gastroenterol, 2010, 10 = 122.
  • 8刘佳,张绍庚,魏炜明,唐荣,乐羿,陈小刚.手助腹腔镜改良Sugiura术在特发性门静脉高压症的临床应用[J].医学研究杂志,2012,41(9):139-142. 被引量:7
  • 9Sarin SK, Kumar A, Chawla YK,et al. Noncirrhotic portal fi-brosis/idiopathic portal hypertension APASL recommenda- tions for diagnosis and treatment[J]. Hepatol Int, 2007, 1 {3) .- 398 -413.
  • 10Chawla Y, Dhiman RK. Intrahepatic portal venopathy and re- lated disorders of the liver[J]. Semin Liver Dis, 2008, 28 {3} 270 -281.

二级参考文献24

共引文献13

同被引文献4

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部